Definiens provides boost for biomarkers
October 12, 2011 -- Imaging software developer Definiens has announced the release of its quantitative digital pathology portfolio designed to advance translational research in pathology, specifically biomarker development.
Agfa launches new nuclear medicine PACS
October 10, 2011 -- Agfa Healthcare is using the venue of the 2011 Congress of the European Association of Nuclear Medicine later this week to introduce the newest version of its Impax for Nuclear Medicine PACS.
OctreoPharm signs deal with Novartis
October 10, 2011 -- German nuclear medicine contrast company OctreoPharm Sciences has received the worldwide exclusive license for the development and commercialization of SOMscan from Novartis Pharma.
GE launches Russian joint venture
September 16, 2011 -- GE Healthcare has created an imaging equipment production joint venture with Russian Technologies, a state company involved in the development, production, and export of high-tech industrial products.
Mirada inks deal with clinical trial firm
September 15, 2011 -- Medical imaging software developer Mirada Medical has signed an agreement with clinical trial support firm ABX-CRO that will allow the company to use Mirada's multimodality imaging applications for clinical trials in oncology and the neurosciences.
Naviscan's PEM gets CE Mark
September 8, 2011 -- PET developer Naviscan has received the CE Mark for both its high-resolution positron emission mammography (PEM) scanner and PET-guided biopsy accessory.